This study retrospectively analyzed the level of serum CEA, IL-1β, IL-6, and IL-8 in patients with lung cancer, and the relationship between levels of these ILs with the pathological type and clinical stage of patients with lung cancer. This evidence concerns the gene CXCL8 and lung carcinoma.